EDITORIAL SECTION

Trethera Corporation Trethera a clinical stage biopharmaceutical company developing firstinclass therapies for cancer and autoimmune diseases announced today that the US Food and Drug Administration

Edwards Lifesciences NYSE EW today announced that the US Food and Drug Administration FDA has approved the AUTUS SizeAdjustable Valve a surgical pulmonary valve designed specifically

Genentech a member of the Roche Group SIX RO ROP OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys New Drug Application NDA

MedImpact the nations largest independent pharmacy benefit and health solutions company today introduced Claria an industryfirst approach that transforms PBM economics by giving plan

Bayer plans to invest billion in a new pharmaceutical manufacturing site in New Albany Ohio in the United States The project is part of the companys longterm growth strategy and will support its focus on innovation and patient access in the US pharmaceutical market

Italfarmaco and JCR Pharmaceuticals have entered into an exclusive licence agreement to develop and potentially commercialise JR in the United States Europe and Latin America subject to regulatory approval

AbbVie has partnered with Valkai a life sciences artificial intelligence AI platform to expand the use of AI across selected areas of clinical development

Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to million subject to the achievement of certain performance milestones

Meitheal Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved a highconcentration formulation of YUSIMRY adalimumabaqvh an interchangeable biosimilar to Humira

Merck known as MSD outside of the United States and Canada and SciBrunch Therapeutics Co Ltd SciBrunch today announced that they have entered into an exclusive global license agreement for SPR an investigational preclinical oral KRAS GD ON inhibitor